Literature DB >> 15173742

Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.

Ann Verrijckt1, François Proulx, Sylvain Morneau, Suzanne Vobecky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15173742     DOI： 10.1016/j.jtcvs.2003.12.021

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  4 in total

Review 1.  The evolution of patient selection criteria and indications for extracorporeal life support in pediatric cardiopulmonary failure: next time, let's not eat the bones.

Authors:  Joseph R Custer
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

2.  Use of thromboelastograph and factor VII for the treatment of postoperative bleeding in a pediatric patient on ECMO after cardiac surgery.

Authors:  Matthew C Davis; Niels E O Andersen; Per Johansson; Lars W Andersen
Journal:  J Extra Corpor Technol       Date:  2006-06

Review 3.  Neonatal respiratory and cardiac ECMO in Europe.

Authors:  Ilaria Amodeo; Matteo Di Nardo; Genny Raffaeli; Shady Kamel; Francesco Macchini; Antonio Amodeo; Fabio Mosca; Giacomo Cavallaro
Journal:  Eur J Pediatr       Date:  2021-02-05       Impact factor: 3.183

4.  Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant.

Authors:  Manish J Gandhi; Richard A Pierce; Lini Zhang; Marc R Moon; George J Despotis; Nader Moazami
Journal:  J Cardiothorac Surg       Date:  2007-07-06       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.